NCT06984848View on ClinicalTrials.gov

Effect of Enzymatic-Containing Mouth Spray (Oral7®) on Xerostomia Symptoms, Salivary Flow Rate, and Oral Health-Related Quality of Life in Older Patients

NANot yet recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

August 1, 2025

Primary Completion Date

May 1, 2026

Study Completion Date

December 1, 2026

Conditions
XerostomiaGeriatric
Interventions
COMBINATION_PRODUCT

Oral7® mouth spray contains Natural Enzymes (Lactoperoxidase, Glucose Oxidase, Lactoferrin, Lysozyme), Calcium, Xylitol, Aloe Vera, Natural peppermint.

This study aims to evaluate the effectiveness of an enzymatic-containing mouth spray (Oral7®) on xerostomia symptoms, unstimulated salivary flow rate, and oral health-related quality of life (OHRQoL) in older patients with xerostomia

All Listed Sponsors
lead

ZAINAB MAT YUDIN

INDUSTRY

NCT06984848 - Effect of Enzymatic-Containing Mouth Spray (Oral7®) on Xerostomia Symptoms, Salivary Flow Rate, and Oral Health-Related Quality of Life in Older Patients | Biotech Hunter | Biotech Hunter